{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:21:09Z","timestamp":1791415269057,"version":"4.3.3"},"reference-count":100,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100019693","name":"Universidade Federal da Fronteira Sul","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["310606\/2021-7"],"award-info":[{"award-number":["310606\/2021-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["404256\/2021-0"],"award-info":[{"award-number":["404256\/2021-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.cpcardiol.2023.102019","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T21:53:21Z","timestamp":1691186001000},"page":"102019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"PA","title":["Current Pharmacology and Modulation of the Purinergic System in Takotsubo Syndrome Triggered by Cytokine Storm"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1652-9692","authenticated-orcid":false,"given":"J\u00falia Le\u00e3o Batista","family":"Sim\u00f5es","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0384-9934","authenticated-orcid":false,"given":"Ge\u00f3rgia de Carvalho","family":"Braga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8576-0070","authenticated-orcid":false,"given":"Tam\u00edres Hillesheim","family":"Mittelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9263-4980","authenticated-orcid":false,"given":"Margarete Dulce","family":"Bagatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2023.102019_bib0001","doi-asserted-by":"crossref","first-page":"3","DOI":"10.25122\/jml-2018-0067","article-title":"Takotsubo cardiomyopathy: a brief review","volume":"13","author":"Amin","year":"2020","journal-title":"J Med Life"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcha.2022.100990","article-title":"Update of Takotsubo cardiomyopathy: present experience and outlook for the future","volume":"39","author":"Bairashevskaia","year":"2022","journal-title":"IJC Heart & Vasculature"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0003","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ihj.2017.09.005","article-title":"Takotsubo syndrome","volume":"70","author":"Gupta","year":"2018","journal-title":"Indian Heart J"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0004","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jjcc.2020.10.004","article-title":"Update of takotsubo syndrome in the era of COVID-19","volume":"77","author":"Okura","year":"2021","journal-title":"J Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0005","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pharmthera.2013.06.002","article-title":"Cardiovascular adenosine receptors: expression, actions and interactions","volume":"140","author":"Headrick","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0006","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.31083\/j.rcm2204130","article-title":"Catecholamine-induced cardiomyopathy: an endocrinologist's perspective","volume":"22","author":"Kumar","year":"2021","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0007","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.jacc.2020.10.060","article-title":"Pathophysiology of Takotsubo syndrome","volume":"77","author":"Lyon","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.cpcardiol.2023.102019_bib0008","doi-asserted-by":"crossref","first-page":"38","DOI":"10.31083\/j.rcm2301038","article-title":"Takotsubo cardiomyopathy","volume":"23","author":"Matta","year":"2022","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0009","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrcardio.2015.39","article-title":"Epidemiology and pathophysiology of Takotsubo syndrome","volume":"12","author":"Akashi","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2020.100763","article-title":"Takotsubo Syndrome and COVID-19: associations and Implications","volume":"46","author":"Shah","year":"2021","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0011","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1161\/CIRCULATIONAHA.121.055854","article-title":"Takotsubo syndrome: pathophysiology, emerging concepts, and clinical implications","volume":"145","author":"Singh","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0012","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10286-017-0465-z","article-title":"Epidemiology, pathogenesis, and management of takotsubo syndrome","volume":"28","author":"Y-Hassan","year":"2018","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0013","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1136\/heartjnl-2016-309783","article-title":"Takotsubo syndrome: aetiology, presentation and treatment","volume":"103","author":"Kato","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0014","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11883-021-00946-z","article-title":"Takotsubo syndrome: uncovering myths and misconceptions","volume":"23","author":"Cammann","year":"2021","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0015","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/jocs.15251","article-title":"Takotsubo cardiomyopathy caused by emotional stressors in the coronavirus disease 2019 (COVID-19) pandemic era","volume":"36","author":"Kir","year":"2021","journal-title":"J Card Surg"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0016","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/abbs\/gmaa176","article-title":"Cardiovascular disease in patients with COVID-19: evidence from cardiovascular pathology to treatment","volume":"53","author":"Luo","year":"2021","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117723","article-title":"Myocardial injury and COVID-19: possible mechanisms","volume":"253","author":"Babapoor-Farrokhran","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0018","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jmv.26232","article-title":"The cytokine storm and COVID-19","volume":"93","author":"Hu","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0019","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41371-020-0387-4","article-title":"COVID-19 and the cardiovascular system: a comprehensive review","volume":"35","author":"Azevedo","year":"2021","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0020","doi-asserted-by":"crossref","first-page":"636","DOI":"10.12688\/f1000research.24457.1","article-title":"Epidemiology of mental health problems in COVID-19: a review","volume":"9","author":"Hossain","year":"2020","journal-title":"F1000Res"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0021","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S2213-8587(20)30342-9","article-title":"Catecholamine physiology and its implications in patients with COVID-19","volume":"8","author":"Gubbi","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0022","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1093\/cvr\/cvab081","article-title":"Metabolic alterations in a rat model of Takotsubo syndrome","volume":"118","author":"Godsman","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0023","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11302-015-9493-0","article-title":"P2X ion channel receptors and inflammation","volume":"12","author":"Burnstock","year":"2016","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0024","doi-asserted-by":"crossref","first-page":"597","DOI":"10.31083\/j.rcm2203071","article-title":"Long-term management of Takotsubo syndrome: a not-so-benign condition","volume":"22","author":"Sclafani","year":"2021","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0025","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ijcard.2017.11.099","article-title":"Effect of sex hormones in Takotsubo cardiomyopathy: just matter of arrhythmias or also outcomes?","volume":"254","author":"Santoro","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0026","first-page":"2689","article-title":"Takotsubo (stress) cardiomyopathy","volume":"373","author":"Pieroni","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0027","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.amjcard.2014.01.419","article-title":"Meta-analysis of clinical correlates of acute mortality in takotsubo cardiomyopathy","volume":"113","author":"Singh","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0028","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1136\/heartjnl-2022-320950","article-title":"\u03b2-blockers and outcomes of Takotsubo syndrome: need more clinical data","volume":"108","author":"Isogai","year":"2022","journal-title":"Heart"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0029","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/CIRCRESAHA.119.315268","article-title":"The medical and device-related treatment of heart failure","volume":"124","author":"Willerson","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ejhf.424","article-title":"Current state of knowledge on Takotsubo syndrome: a position statement from the taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology","volume":"18","author":"Lyon","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0031","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1093\/eurheartj\/ehy076","article-title":"International Expert Consensus Document on Takotsubo syndrome (Part I): clinical characteristics, diagnostic criteria, and pathophysiology","volume":"39","author":"Ghadri","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0032","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMoa1406761","article-title":"Clinical features and outcomes of Takotsubo (stress) cardiomyopathy","volume":"373","author":"Templin","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0033","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijcard.2021.01.015","article-title":"Takotsubo syndrome: any more covariates of its recurrence?","volume":"330","author":"Madias","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0034","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.amjcard.2020.12.004","article-title":"COVID-19, POCUS, and Takotsubo","volume":"141","author":"Madias","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11302-014-9436-1","article-title":"Cardiac purinergic signalling in health and disease","volume":"11","author":"Burnstock","year":"2015","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0036","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/cvr\/21.2.81","article-title":"Role of adenosine in mediating the coronary vasodilative response to acute hypoxia","volume":"21","author":"Gewirtz","year":"1987","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0037","first-page":"H955","article-title":"Canine coronary vasodepressor responses to hypoxia are attenuated but not abolished by 8-phenyltheophylline","volume":"262","author":"Lee","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0038","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1549-8719.2010.00054.x","article-title":"Contribution of adenosine A2A and A2B receptors to ischemic coronary dilation: role of KV and KATP channels","volume":"17","author":"Berwick","year":"2010","journal-title":"Microcirculation"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0039","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1113\/jphysiol.2005.100115","article-title":"Adenosine concentration in the porcine coronary artery wall and A2A receptor involvement in hypoxia-induced vasodilatation","volume":"570","author":"Fr\u00f8bert","year":"2006","journal-title":"J Physiol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0040","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/cvr\/27.9.1592","article-title":"Endogenous adenosine and coronary vasoconstriction in hypoperfused myocardium during exercise","volume":"27","author":"Duncker","year":"1993","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0041","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1748-1716.1983.tb07300.x","article-title":"Influence of adenosine on the vascular responses to sympathetic nerve stimulation in the canine subcutaneous adipose tissue","volume":"119","author":"Sollevi","year":"1983","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0042","first-page":"H2420","article-title":"Mechanism of the negative inotropic effect of adenosine in guinea pig atrial myocytes","volume":"267","author":"Wang","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0043","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1440-1681.2009.05300.x","article-title":"Adenosine A1 receptor activation reduces opening of mitochondrial permeability transition pores in hypoxic cardiomyocytes","volume":"37","author":"Xiang","year":"2010","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0044","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/ndt\/gfl665","article-title":"Influence of haemodialysis and left ventricular failure on peripheral A(2A) adenosine receptor expression","volume":"22","author":"Carrega","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0045","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0140-6736(12)61144-1","article-title":"New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis","volume":"380","author":"Fernandez","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0046","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1513\/pats.201203-023AW","article-title":"The impact of TGF-\u03b2 on lung fibrosis: from targeting to biomarkers","volume":"9","author":"Fernandez","year":"2012","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0047","first-page":"577","article-title":"Functional implications of sole and selective activation of intravascular coronary endothelial hormonal receptors","volume":"21","author":"Rubio","year":"2000","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0048","doi-asserted-by":"crossref","first-page":"18678","DOI":"10.1074\/jbc.271.31.18678","article-title":"A new cyclic AMP-independent, Gs-mediated stimulatory mechanism via the adenosine A2a receptor in the intact cardiac cell","volume":"271","author":"Liang","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0049","doi-asserted-by":"crossref","first-page":"H1472","DOI":"10.1152\/ajpheart.2000.279.4.H1472","article-title":"Adenosine A(2a)-receptor activation increases contractility in isolated perfused hearts","volume":"279","author":"Monahan","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0050","doi-asserted-by":"crossref","first-page":"40104","DOI":"10.1074\/jbc.M110.184606","article-title":"Inactivation of adenosine A2A receptor attenuates basal and angiotensin II-induced ROS production by Nox2 in endothelial cells","volume":"285","author":"Thakur","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0051","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1100\/tsw.2011.22","article-title":"Anti-inflammatory and immunosuppressive effects of the A2A adenosine receptor","volume":"11","author":"Milne","year":"2011","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0052","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/sj.onc.1206184","article-title":"Adenosine suppresses activation of nuclear factor-kappaB selectively induced by tumor necrosis factor in different cell types","volume":"22","author":"Majumdar","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0053","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1517\/13543780903203789","article-title":"Targeting IL-6 in the treatment of inflammatory and autoimmune diseases","volume":"18","author":"Ding","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0054","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3389\/fphar.2017.00661","article-title":"Purinergic signalling: therapeutic developments","volume":"8","author":"Burnstock","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0055","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12872-020-01580-4","article-title":"The relationship of lipoprotein-associated phospholipase A2 activity with the seriousness of coronary artery disease","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0056","doi-asserted-by":"crossref","first-page":"e14269","DOI":"10.14814\/phy2.14269","article-title":"Alpha-calcitonin gene-related peptide prevents pressure-overload induced heart failure: role of apoptosis and oxidative stress","volume":"7","author":"Kumar","year":"2019","journal-title":"Physiol Rep"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0057","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1021\/jm301372c","article-title":"5\u2019-Phosphate and 5\u2019-phosphonate ester derivatives of (N)-methanocarba adenosine with in vivo cardioprotective activity","volume":"56","author":"Kumar","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0058","doi-asserted-by":"crossref","DOI":"10.1007\/s00395-012-0317-x","article-title":"Purinergic signalling in the rostral ventro-lateral medulla controls sympathetic drive and contributes to the progression of heart failure following myocardial infarction in rats","volume":"108","author":"Marina","year":"2013","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0059","doi-asserted-by":"crossref","first-page":"9585","DOI":"10.1523\/JNEUROSCI.2569-04.2004","article-title":"Na-K-Cl cotransporter-mediated intracellular Na+ accumulation affects Ca2+ signaling in astrocytes in an in vitro ischemic model","volume":"24","author":"Lenart","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0060","first-page":"1819","article-title":"P2Y1 receptor antagonists mitigate oxygen and glucose deprivationinduced astrocyte injury","volume":"17","author":"Guo","year":"2018","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0061","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11302-013-9352-9","article-title":"Purinergic and glutamatergic interactions in the hypothalamic paraventricular nucleus modulate sympathetic outflow","volume":"9","author":"Ferreira-Neto","year":"2013","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0062","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00210-009-0403-2","article-title":"P2 purinergic receptor mRNA in rat and human sinoatrial node and other heart regions","volume":"379","author":"Musa","year":"2009","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0063","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21145005","article-title":"Resolving the Ionotropic P2X4 receptor mystery points towards a new therapeutic target for cardiovascular diseases","volume":"21","author":"Bragan\u00e7a","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0064","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3389\/fphar.2019.01103","article-title":"The ionotropic P2X4 Receptor has unique properties in the heart by mediating the negative chronotropic effect of ATP while increasing the ventricular inotropy","volume":"10","author":"Bragan\u00e7a","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0065","doi-asserted-by":"crossref","first-page":"H1191","DOI":"10.1152\/ajpheart.00577.2008","article-title":"Role of P2X purinergic receptors in the rescue of ischemic heart failure","volume":"295","author":"Sonin","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0066","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1248\/yakushi.130.1407","article-title":"[Blood flow sensing mechanism via calcium signaling in vascular endothelium]","volume":"130","author":"Yamamoto","year":"2010","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0067","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nm1338","article-title":"Impaired flow-dependent control of vascular tone and remodeling in P2X4-deficient mice","volume":"12","author":"Yamamoto","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0068","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1023\/A:1010828302936","article-title":"P2X (purinergic) receptor redistribution in rabbit aorta following injury to endothelial cells and cholesterol feeding","volume":"29","author":"Pulvirenti","year":"2000","journal-title":"J Neurocytol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0069","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1476-5381.1991.tb12432.x","article-title":"Vasodilator response of coronary smooth muscle to the sympathetic co-transmitters noradrenaline and adenosine 5\u2019-triphosphate","volume":"104","author":"Corr","year":"1991","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0070","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0022-3565(25)11338-4","article-title":"Purinergic relaxation and hyperpolarization in guinea pig and rabbit coronary artery: role of the endothelium","volume":"260","author":"Keef","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0071","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jacc.2012.11.032","article-title":"Ticagrelor enhances adenosine-induced coronary vasodilatory responses in humans","volume":"61","author":"Wittfeldt","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0072","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/sj.bjp.0703536","article-title":"The stable pyrimidines UDP\u03b2S and UTP\u03b3S discriminate between the P2 receptors that mediate vascular contraction and relaxation of the rat mesenteric artery","volume":"131","author":"Malmsj\u00f6","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0073","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/00005344-199405000-00010","article-title":"Differential effects of ATP- and 2-methylthioATP-induced relaxation in guinea pig coronary vasculature","volume":"23","author":"Vials","year":"1994","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0074","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/sj.bjp.0702610","article-title":"Intravascular ATP and coronary vasodilation in the isolated working rat heart","volume":"127","author":"Korchazhkina","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0075","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1152\/japplphysiol.00946.2011","article-title":"Functional contribution of P2Y1 receptors to the control of coronary blood flow","volume":"111","author":"Bender","year":"2011","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0076","doi-asserted-by":"crossref","first-page":"H1077","DOI":"10.1152\/ajpheart.01046.2004","article-title":"Arachidonic acid metabolites, hydrogen peroxide, and EDHF in cerebral arteries","volume":"289","author":"You","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0077","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1111\/j.1538-7836.2004.00926.x","article-title":"Adenine triphosphate nucleotides are antagonists at the P2Y receptor","volume":"2","author":"Kauffenstein","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0078","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1016\/j.jid.2018.02.023","article-title":"Alteration of extracellular nucleotide metabolism in pseudoxanthoma elasticum","volume":"138","author":"Kauffenstein","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0079","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2017.06.020","article-title":"The P2X7 receptor in infection and inflammation","volume":"47","author":"Virgilio","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0080","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1111\/bph.15138","article-title":"A rationale for targeting the P2X7 receptor in Coronavirus disease 19","volume":"177","author":"di Virgilio","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0081","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/sj.bjp.0707213","article-title":"P2X receptor characterization and IL-1\/IL-1Ra release from human endothelial cells","volume":"151","author":"Wilson","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0082","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1161\/01.CIR.87.3.900","article-title":"Adenosine alters glucose use during ischemia and reperfusion in isolated rat hearts","volume":"87","author":"Finegan","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0083","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/sj.bjp.0702765","article-title":"Alteration of glycogen and glucose metabolism in ischaemic and post-ischaemic working rat hearts by adenosine A1 receptor stimulation","volume":"128","author":"Fraser","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0084","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/bph.13339","article-title":"Adenosine A1 receptor activation attenuates cardiac hypertrophy and fibrosis in response to \u03b11 -adrenoceptor stimulation in vivo","volume":"173","author":"Puhl","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0085","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10741-015-9522-7","article-title":"Partial adenosine A1 receptor agonism: a potential new therapeutic strategy for heart failure","volume":"21","author":"Greene","year":"2016","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0086","doi-asserted-by":"crossref","first-page":"e18048","DOI":"10.1371\/journal.pone.0018048","article-title":"Selective attenuation of norepinephrine release and stress-induced heart rate increase by partial adenosine A1 agonism","volume":"6","author":"Bott-Fl\u00fcgel","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0087","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/1440-1681.12616","article-title":"VCP746, a novel A1 adenosine receptor biased agonist, reduces hypertrophy in a rat neonatal cardiac myocyte model","volume":"43","author":"Chuo","year":"2016","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0088","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4103\/0976-9234.177076","article-title":"Dipyridamole in heart failure due to dilated cardiomyopathy: a pilot study","volume":"7","author":"Stea","year":"2016","journal-title":"J Pharm Negat Results"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0089","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1527-5299.2007.06047.x","article-title":"Effect of chronic sustained-release dipyridamole on myocardial blood flow and left ventricular function in patients with ischemic cardiomyopathy","volume":"13","author":"Akhtar","year":"2007","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0090","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pharmthera.2018.08.015","article-title":"Myocardial metabolism in heart failure: purinergic signalling and other metabolic concepts","volume":"194","author":"Birkenfeld","year":"2019","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0091","doi-asserted-by":"crossref","first-page":"866","DOI":"10.2174\/1381612826666201001125604","article-title":"Potential therapeutic benefits of dipyridamole in COVID-19 patients","volume":"27","author":"Aliter","year":"2021","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0092","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.nuclcard.2007.02.016","article-title":"Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans","volume":"14","author":"Lieu","year":"2007","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0093","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1007\/s00259-011-1853-6","article-title":"Comparison of the myocardial blood flow response to regadenoson and dipyridamole: a quantitative analysis in patients referred for clinical 82Rb myocardial perfusion PET","volume":"38","author":"Goudarzi","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0094","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1532-429X-15-85","article-title":"Regadenoson and adenosine are equivalent vasodilators and are superior than dipyridamole- a study of first pass quantitative perfusion cardiovascular magnetic resonance","volume":"15","author":"Vasu","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0095","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.thromres.2009.06.029","article-title":"Comparison of ticagrelor and thienopyridine P2Y(12) binding characteristics and antithrombotic and bleeding effects in rat and dog models of thrombosis\/hemostasis","volume":"124","author":"van Giezen","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0096","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1124\/jpet.109.164376","article-title":"Treatment of heart failure by a methanocarba derivative of adenosine monophosphate: Implication for a role of cardiac purinergic P2X receptors","volume":"333","author":"Zhou","year":"2010","journal-title":"J Pharmacol Exp Therap"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0097","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1096\/fasebj.25.1_supplement.1085.10","article-title":"Cardioprotective effects of the P2X receptor agonist MRS2339 in dog and mouse models of heart failure","volume":"25","author":"Patel","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0098","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11302-020-09688-0","article-title":"Prevention and rescue of cardiac dysfunction by methanocarba adenosine monophosphonate derivatives","volume":"16","author":"Shen","year":"2020","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0099","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11302-020-09688-0","article-title":"Prevention and rescue of cardiac dysfunction by methanocarba adenosine monophosphonate derivatives","volume":"16","author":"Shen","year":"2020","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.cpcardiol.2023.102019_bib0100","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1160\/TH09-05-0305","article-title":"Human solCD39 inhibits injury-induced development of neointimal hyperplasia","volume":"103","author":"Drosopoulos","year":"2010","journal-title":"Thromb Haemost"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014628062300436X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014628062300436X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:15:35Z","timestamp":1758939335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014628062300436X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S014628062300436X"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.102019","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current Pharmacology and Modulation of the Purinergic System in Takotsubo Syndrome Triggered by Cytokine Storm","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.102019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"102019"}}